Supplements in conjunction with HRT
<p>From: Traumatic Brain Injury, Panhypopituitarism and Hormonal Evaluations as a Standard of Care
<a href="http://www.nevadaosteopathic.org/attachments/article/33/Clearfield%20Panhypopituitarism%20and%20TBI.pdf">http://www.nevadaosteopathic.org/attachments/article/33/Clearfield%20Panhypopituitarism%20and%20TBI.pdf</a></p>
<p><img src="/b61ff6ff-6880-43f4-92da-453646bc720d.png" /></p>
<p><img src="/64030d0f-4c98-487b-ab89-bd13b51bdf90.png" /></p>
<p><img src="/874c5f6f-19e4-47a4-8274-9f45024c0d5d.png" /></p>
<p><img src="/343fc3c8-2a71-4089-92ad-c5e7dad8ccfd.png" /></p>
<p><img src="/845d35e2-6014-422f-84cf-e263409e2037.png" /></p>
<p><img src="/c45a7fb8-1db2-47d1-9cc9-463870a6cf0b.png" /></p>
<p><img src="/3855d3a2-c710-45e7-8079-6e72e03306d7.png" /></p>
<p><img src="/d3a46be2-0753-4691-9fc0-9c727af95e8c.png" /></p>
<p><img src="/4453e809-8389-4f6a-ac37-977e6c140790.png" /></p>
<p><img src="/2ba304b4-1643-4597-9932-ac0db69359ee.png" /></p>
<p><img src="/368d3f7f-6805-412f-8473-aadaec81706d.png" /></p>
<p><img src="/34fdfe28-75a5-4f42-a828-7b4cb8c27d97.png" /></p>
<p><img src="/3254388b-2c5b-4a32-aac8-957763d7e6bf.png" /></p>
<p><img src="/024d7442-9b6d-4eda-a379-c72322b476c8.png" /></p>
<p><img src="/7028d307-4892-4b8a-9310-e2f3babd84f5.png" /></p>
<p><img src="/281cd6b2-969f-4cac-8e8d-282750aefb1f.png" /></p>
<p><img src="/be772733-252f-4d13-9dd0-728fbdc13294.png" /></p>
<p><img src="/b079514d-cb0d-46c3-92b2-ee562b48588c.png" /></p>
<p><img src="/17332be6-71f9-4992-9f4a-5855285a244e.png" /></p>
<p><img src="/2610d922-e5b5-447c-be10-dd922362486c.png" /></p>
<p><img src="/7549f99c-8f04-422a-9c0d-1fc034cc7d10.png" /></p>
<p><img src="/00097190-a079-489c-a766-38debfd8d748.png" /></p>
<p><img src="/5f258041-c258-4e40-a79a-0d521960980a.png" /></p>
<p> </p>
<p>L-Dopa Raises Growth Hormone
• Oral doses (0.5 g) caused a significant rise in plasma GH.
• The rise in plasma GH persisted for 120 minutes after the administration of the drug.
• The data suggest that a dopaminergic mechanism in the median eminence or a norepinephrine-sensitive site in the hypothalamus or limbic system may be involved in the regulation of growth-hormone secretion.
• Parkinson's disease patients, on L-dopa therapy, enjoy an elevated plasma GH for a substantial part of the day
Stimulation of Human-Growth-Hormone Secretion by L-Dopa. N Engl J Med 1970; 283:1425-1429 Dec. 24, 1970. A. E. Boyd, III, M.D., Harold E. Lebovitz, M.D., and John B. Pfeiffer, M.D. From the divisions of Endocrinology and Neurology, Department of Medicine, Duke University Medical Center</p>